+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The safety of beta-propiolactone as a biologic sterilizing agent. Clinical evaluation with human plasma and homotransplants

The safety of beta-propiolactone as a biologic sterilizing agent. Clinical evaluation with human plasma and homotransplants

Angiology 12: 80-83

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 050728213

Download citation: RISBibTeXText

PMID: 13763188

Related references

The Safety of -Propiolactone as a Biologic Sterilizing Agent: Clinical Evaluation With Human Plasma and Homotransplants. Angiology 12(2): 80-83, 1961

The safety of beta-propiolactone as a biologic sterilizing agent. Angiology 12(2): 80-83, 1960

Beta-propiolactone as a sterilizing agent in the manufacture of intravenous immunoglobulin preparations. Arzneimittel-Forschung 33(9): 1230-1231, 1983

Beta-propiolactone as sterilizing agent in collection of bone homo- and heterotransplants. Ortop Travmatol Protez 27(4): 53-56, 1966

Beta-propiolactone as a sterilizing agent in the preparation of homo- and heterologous bone transplants. Ortopediia Travmatologiia i Protezirovanie 27(4): 53-56, 1966

Virus safety of beta-propiolactone treated plasma preparations. Clinical experiences. Developments in Biological Standardization 67: 311-317, 1987

Clinical evaluation of the hepatitis safety of a beta-propiolactone/ultraviolet treated factor IX concentrate (PPSB). Thrombosis Research 28(1): 75-83, 1982

Beta-propiolactone plus ultraviolet irradiated plasma. A clinical evaluation for hepatitis, toxicity and allergy. Proc Congr Int Soc Blood Transfus 9: 644-647, 1962

Beta-Propiolactone Plus Ultraviolet Irradiated Plasma. a Clinical Evaluation for Hepatitis, Toxicity and Allergy. Bibliotheca Haematologica 19: 644-647, 1964

Clinico-morphologic study of valve homotransplants sterilized with beta-propiolactone. Grudnaia Khirurgiia 13(4): 32-37, 1971

Human Plasma Treated with Ultraviolet and Propiolactone. Six-Year Clinical Evaluation. JAMA 187: 722-726, 1964

Virus inactivation in human plasma and plasma fractions by means of beta propiolactone beta pl and beta pl uv. Stoltz, J F And C Rivat (Ed ) Colloque Inserm (Institut National De La Sante Et De La Recherche Medicale), Vol 175 Biotechnologie Des Proteines Du Plasma: Purification Et Utilisations Cliniques Et Biologiques; (Inserm (National Institute Of Health And Medical Research) Colloquium), Vol 175 Biotechnology Of Plasma Proteins: Fractionation And Applications; International Symposium, Nancy, France, May 17-19, 1988 Xii+501p Les Editions Inserm: Paris, France Illus Paper 391-398, 198, 1989

Analysis of beta-propiolactone by gas chromatography. I. A residue of beta-propiolactone in rabies vaccine. II. Hydrolysis of beta-propiolactone at pH 7.4. Journal of Chromatography 70(1): 128-134, 1972

A clinical study of the tolerance and safety of a beta-propiolactone-treated immunoglobulin. Arzneimittel-Forschung 31(11): 1928-1930, 1981

Inactivation of viruses by beta-propiolactone in human cryo poor plasma and IgG concentrates. Biologicals 26(2): 135-144, 1998